State Variations In The Out-Of-Pocket Spending Burden For Outpatient Mental Health Treatment

被引:11
作者
Zuvekas, Samuel H. [1 ]
Meyerhoefer, Chad D. [2 ]
机构
[1] Agcy Healthcare Res & Qual, Ctr Financing Access & Cost Trends, Rockville, MD USA
[2] Lehigh Univ, Dept Econ, Bethlehem, PA 18015 USA
关键词
SERVICES; PARITY; 2ND-GENERATION; SCHIZOPHRENIA; INSURANCE; DEMAND; TRIAL; DRUGS; CARE;
D O I
10.1377/hlthaff.28.3.713
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
We examine the potential of mental health/substance abuse (MH/SA) parity laws to reduce the out-of-pocket spending burden for outpatient treatment at the state level by exploring cross-state variations and their causes, as well as the provisions of MH/SA parity laws. We find modest (yet important) variation in out-of-pocket burden across states overall, but-because prescription medications account for two-thirds of out-of-pocket spending and are generally beyond the scope of recently enacted federal parity laws-evidence suggests that those laws will do little to reduce the observed burden or its variation. Other policy measures, designed to expand and improve health insurance coverage or reduce racial/ethnic disparities, could have a more profound impact. [Health Affairs 28, no. 3 (2009): 713-722; 10.1377/hlthaff.28.3.713]
引用
收藏
页码:713 / 722
页数:10
相关论文
共 19 条
  • [1] Changes in financial burdens for health care - National estimates for the population younger than 65 years, 1996 to 2003
    Banthin, Jessica S.
    Bernard, Didem M.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (22): : 2712 - 2719
  • [2] BUCHMUELLER, 2004, HEALTH SERV RES, V39, P1361
  • [3] Parity for whom? Exemptions and the extent of state mental health parity legislation
    Buchmueller, Thomas C.
    Cooper, Philip F.
    Jacobson, Mireille
    Zuvekas, Samuel H.
    [J]. HEALTH AFFAIRS, 2007, 26 (04) : W483 - W487
  • [4] Behavioral health insurance parity for Federal Employees
    Goldman, HH
    Frank, RG
    Burnam, MA
    Huskamp, HA
    Ridgely, MS
    Normand, SLT
    Young, AS
    Barry, CL
    Azzone, V
    Busch, AB
    Azrin, ST
    Moran, G
    Lichtenstein, C
    Blasinsky, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (13) : 1378 - 1386
  • [5] Hendryx M, 2008, J MENT HEALTH POLICY, V11, P17
  • [6] HONBERG, GRADING STATES
  • [7] HORGAN CM, 1986, HEALTH SERV RES, V21, P291
  • [8] Managing psychotropic drug costs: Will formularies work?
    Huskamp, HA
    [J]. HEALTH AFFAIRS, 2003, 22 (05) : 84 - 96
  • [9] Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia - Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1)
    Jones, Peter B.
    Barnes, Thomas R. E.
    Davies, Linda
    Dunn, Graham
    Lloyd, Helen
    Hayhurst, Karen P.
    Murray, Robin M.
    Markwick, Alison
    Lewis, Shon W.
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2006, 63 (10) : 1079 - U6
  • [10] THE DEMAND FOR EPISODES OF MENTAL-HEALTH SERVICES
    KEELER, EB
    MANNING, WG
    WELLS, KB
    [J]. JOURNAL OF HEALTH ECONOMICS, 1988, 7 (04) : 369 - 392